<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 35-year old woman developed Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and was treated with rituximab and CHOP therapy early during pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Monitoring of rituximab concentrations and B-cell counts in the child revealed a transient complete B-cell <z:mpath ids='MPATH_63'>depletion</z:mpath> associated with high rituximab cord blood concentrations </plain></SENT>
<SENT sid="2" pm="."><plain>B-cell recovery was fast, showing a regular immunophenotype without loss of CD20 antigen, no functional deficits and adequate vaccination IgG titers </plain></SENT>
</text></document>